$INCR Cashflow Statement | Understand Stock

$INCR

$4.47 +$0.20 (4.68%) Close

$INCR Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of ILS, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities
Opening balance
Interest paid
Taxes paid
Adjustments required to present cash flows from operating activities (A)
Disposal (acquisition) of subsidiary, net of cash against share issuance (Note 8)
Investment in associate(Note 8)
Deconsolidation of subsidiaries, net of cash (Note 8)
Purchase of property, plant and equipment
Additions to right-of-use assets
Issuance of shares and warrants
De-recognition of non-controlling interests
Trade and other receivables
Inventory and biological assets
Property, plant, equipment and right-of-use asset
Trade and other payables
Short term loan
Short term loan to related parties
Goodwill
Issuance of shares
Non-controlling interests
Contingent consideration
Payables due to acquisition
Deferred consideration
Deferred tax assets (liabilities)
Lease liability
Financial assets measured at fair value through profit or loss
Total acquisition of subsidiary, net of cash
Payables for deferred consideration due to acquisitions
Loss (gain)
Total disposal of subsidiary, net of cash
Net cash provided by (used in) operating activities

Cash flows from investing activities
Purchase of property, plant and equipment
Loans granted (Note 12B)
Increase in restricted cash
Decrease in restricted cash
Payment of deferred consideration for acquisitions
Acquisition of Subsidiaries, net of cash acquired (Note 8)
Loan to associate (Note 8)
Increase in deposit
Acquisition of subsidiary, net of cash (Note 8)
Grant of loan measured at fair value through profit or loss (Note 8)
Settlement of obligation to issue shares
Investment in assets measured at fair value through profit or loss
Deconsolidation of subsidiaries, net of cash (Note 8)
Investments in equity accounted investee
Brand acquisition
Repayment of loans granted
Proceeds from sales of property, plant and equipment
Interest received
Payments of contingent consideration
Net cash provided by (used in) investing activities

Cash flows from financing activities
Proceeds from issuance of shares as part of private issuance, net
Exercise of share options (Note 18)
Issuance of shares and warrants (Note 18I)
Lease payments
Receipt of loans from banks
Repayment of loans from banks
Dividend distribution to non-controlling interests
Repayment of loan from related party
Receipt of loan from related party and controlling shareholder
Interest paid
Net cash provided by (used in) financing activities

Decrease in cash and cash equivalents
Exchange differences in respect of balances of cash and cash equivalents
Balance of cash and cash equivalents at beginning of year
Balance of cash and cash equivalents at end of year
Adjustments to items in the Consolidated Statements of Profit or Loss and Other Comprehensive Income:
Gain from deconsolidation of subsidiaries
Impairment losses on property, plant and equipment
Impairment losses on goodwill
Changes in loan measured at fair value through profit or loss
Depreciation
Share-based payment (Note 18M)
Changes in the fair value of financial assets through profit or loss, net
Finance expenses, net
Remeasurement of contingent consideration
Tax expense (benefit)
Loss on sale of property, plant and equipment
Changes in loan from non-controlling interest
Gain in respect of acquisition of a subsidiary
Change in liabilities in respect of employee benefits, net
Change in consideration payable in shares
Total Adjustments of comprehensive income
Changes in assets and liabilities items:
Decrease (increase) in trade receivables
Increase (decrease) in other receivables
Decrease (increase) in inventory
Decrease (increase) in biological assets
Increase in trade payables
Increase in other payables
Total of changes in assets and liabilities

Comments